Abstract
Ethnomedicinal plants have been used as source of candidate drugs for almost all diseases, but the number of compounds having antiviral activity is scarce. Irrespective of type of viruses and the cells they infect, there are a very few specific viral targets for the natural molecules to interact. Most of the available antiviral drugs often lead to the development of viral resistance coupled with the problem of side effects, recurrence and viral latency. A wide array of ethnomedicinal plants showed high level of antiviral activities and many of them have complementary and overlapping mechanism of action, either inhibiting viral replication, or viral genome synthesis. Hence, there is an urgent need to develop new antivirals of natural origin. This review will cover some of the promising antiviral compounds isolated from ethnomedicinal plants with proven in vitro and some documented in vivo activities, along with their structure activity relationship.
Keywords: Ethnomedicine, antivirals, structure activity relationship (SAR), HSV, HIV
Mini-Reviews in Medicinal Chemistry
Title: Antivirals of Ethnomedicinal Origin: Structure-activity Relationship and Scope
Volume: 7 Issue: 3
Author(s): Debprasad Chattopadhyay and Trailokya N. Naik
Affiliation:
Keywords: Ethnomedicine, antivirals, structure activity relationship (SAR), HSV, HIV
Abstract: Ethnomedicinal plants have been used as source of candidate drugs for almost all diseases, but the number of compounds having antiviral activity is scarce. Irrespective of type of viruses and the cells they infect, there are a very few specific viral targets for the natural molecules to interact. Most of the available antiviral drugs often lead to the development of viral resistance coupled with the problem of side effects, recurrence and viral latency. A wide array of ethnomedicinal plants showed high level of antiviral activities and many of them have complementary and overlapping mechanism of action, either inhibiting viral replication, or viral genome synthesis. Hence, there is an urgent need to develop new antivirals of natural origin. This review will cover some of the promising antiviral compounds isolated from ethnomedicinal plants with proven in vitro and some documented in vivo activities, along with their structure activity relationship.
Export Options
About this article
Cite this article as:
Chattopadhyay Debprasad and Naik N. Trailokya, Antivirals of Ethnomedicinal Origin: Structure-activity Relationship and Scope, Mini-Reviews in Medicinal Chemistry 2007; 7 (3) . https://dx.doi.org/10.2174/138955707780059844
DOI https://dx.doi.org/10.2174/138955707780059844 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenomics and Personalized Medicine for the Developing World - Too Soon or Just-in-Time? A Personal View from the World Health Organization
Current Pharmacogenomics and Personalized Medicine Antimicrobial Sulfated Glycans: Structure and Function
Current Topics in Medicinal Chemistry Structure Function Analysis of West Nile Virus RNA Dependent RNA Polymerase: Molecular Model and Implications for Drug Design
Medicinal Chemistry Immunopotentiation for Bacterial Biodefense
Current Topics in Medicinal Chemistry Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Antimicrobial Effect of Garlic (Allium sativum)
Recent Patents on Anti-Infective Drug Discovery Patent Selections
Recent Patents on DNA & Gene Sequences Drug Targets in Herpes Simplex and Epstein Barr Virus Infections
Infectious Disorders - Drug Targets Capacity Building in Genomics Medicine and Molecular Diagnostics: The Case of Sri Lanka
Current Pharmacogenomics and Personalized Medicine Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases
Current Enzyme Inhibition Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Infection and Anemia
Infectious Disorders - Drug Targets Editorial (Thematic Issue: The Monocyte/Macrophage in the Pathogenesis of AIDS: The Next Frontier for Therapeutic Intervention in the CNS and Beyond: Part I)
Current HIV Research Viral Inactivation Based on Inhibition of Membrane Fusion: Understanding the Role of Histidine Protonation to Develop New Viral Vaccines
Protein & Peptide Letters Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) COVID-19 and Neurology: An Emerging Association
Infectious Disorders - Drug Targets Using Functional Neuroimaging to Investigate the Mechanisms of Action of Selective Serotonin Reuptake Inhibitors (SSRIs)
Current Pharmaceutical Design Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker
Current Medicinal Chemistry β-Catenin/TCF-4 Signaling Regulates Susceptibility of Macrophages and Resistance of Monocytes to HIV-1 Productive Infection
Current HIV Research Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science